Xeris Biopharma Holdings, Inc. - COM (XERS) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / COM
Symbol
XERS on Nasdaq
Price per share
$7.85
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
96,902,244
Total reported value
$788,823,033
% of total 13F portfolios
0%
Share change
+5,843,407
Value change
+$58,408,445
Number of holders
228
Price from insider filings
$7.85
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 228 institutional investors reported holding 96,902,244 shares of Xeris Biopharma Holdings, Inc. - COM (XERS).

Institutional Holders of Xeris Biopharma Holdings, Inc. - COM (XERS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 212,059 $1,637,067 +$500,437 $7.85 7
2025 Q3 96,902,244 $788,823,033 +$58,408,445 $8.14 228
2025 Q2 90,495,534 $422,617,978 +$16,622,099 $4.67 200
2025 Q1 86,799,982 $476,523,219 +$123,724,865 $5.49 199
2024 Q4 65,550,345 $222,191,453 +$5,687,551 $3.39 161
2024 Q3 63,918,467 $182,169,358 +$11,712,701 $2.85 144
2024 Q2 60,623,914 $136,403,522 +$58,570 $2.25 133
2024 Q1 60,494,491 $133,688,981 +$1,103,388 $2.21 139
2023 Q4 55,877 $131,311 +$4,773 $2.35 1
2023 Q3 55,319,172 $102,889,465 -$2,383,427 $1.86 109
2023 Q2 55,920,487 $146,506,554 +$17,809,997 $2.62 101
2023 Q1 49,463,144 $80,622,456 -$5,927,552 $1.63 89
2022 Q4 53,864,751 $71,635,144 -$5,391,807 $1.33 93
2022 Q3 49,026,066 $76,484,570 -$3,676,770 $1.56 94
2022 Q2 59,179,806 $91,133,115 +$12,092,547 $1.54 93
2022 Q1 50,404,061 $129,033,000 +$23,930,607 $2.56 95
2021 Q4 40,960,411 $120,028,000 +$117,927,338 $2.93 83
2021 Q3 704,170 $1,725,000 +$1,725,005 $2.45 1